Taken together these data have furthered the understanding of the host RNS response to mycobacterial infection and identifies iNOS as a potential host-derived drug target to increase the host RNS response to combat infection, a strategy that should bypass multi-drug resistance mechanisms of the bacteria. This evidence concerns the gene NOS2 and infection.